First Time Loading...

Somalogic Inc
NASDAQ:SLGC

Watchlist Manager
Somalogic Inc Logo
Somalogic Inc
NASDAQ:SLGC
Watchlist
Price: 2.1 USD -4.55% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

SLGC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

SomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. [ Read More ]

The intrinsic value of one SLGC stock under the Base Case scenario is 3.63 USD. Compared to the current market price of 2.1 USD, Somalogic Inc is Undervalued by 42%.

Key Points:
SLGC Intrinsic Value
Base Case
3.63 USD
Undervaluation 42%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Somalogic Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SLGC stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Somalogic Inc

Provide an overview of the primary business activities
of Somalogic Inc.

What unique competitive advantages
does Somalogic Inc hold over its rivals?

What risks and challenges
does Somalogic Inc face in the near future?

Has there been any significant insider trading activity
in Somalogic Inc recently?

Summarize the latest earnings call
of Somalogic Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Somalogic Inc.

Provide P/S
for Somalogic Inc.

Provide P/E
for Somalogic Inc.

Provide P/OCF
for Somalogic Inc.

Provide P/FCFE
for Somalogic Inc.

Provide P/B
for Somalogic Inc.

Provide EV/S
for Somalogic Inc.

Provide EV/GP
for Somalogic Inc.

Provide EV/EBITDA
for Somalogic Inc.

Provide EV/EBIT
for Somalogic Inc.

Provide EV/OCF
for Somalogic Inc.

Provide EV/FCFF
for Somalogic Inc.

Provide EV/IC
for Somalogic Inc.

Show me price targets
for Somalogic Inc made by professional analysts.

What are the Revenue projections
for Somalogic Inc?

How accurate were the past Revenue estimates
for Somalogic Inc?

What are the Net Income projections
for Somalogic Inc?

How accurate were the past Net Income estimates
for Somalogic Inc?

What are the EPS projections
for Somalogic Inc?

How accurate were the past EPS estimates
for Somalogic Inc?

What are the EBIT projections
for Somalogic Inc?

How accurate were the past EBIT estimates
for Somalogic Inc?

Compare the revenue forecasts
for Somalogic Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Somalogic Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Somalogic Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Somalogic Inc compared to its peers.

Compare the P/E ratios
of Somalogic Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Somalogic Inc with its peers.

Analyze the financial leverage
of Somalogic Inc compared to its main competitors.

Show all profitability ratios
for Somalogic Inc.

Provide ROE
for Somalogic Inc.

Provide ROA
for Somalogic Inc.

Provide ROIC
for Somalogic Inc.

Provide ROCE
for Somalogic Inc.

Provide Gross Margin
for Somalogic Inc.

Provide Operating Margin
for Somalogic Inc.

Provide Net Margin
for Somalogic Inc.

Provide FCF Margin
for Somalogic Inc.

Show all solvency ratios
for Somalogic Inc.

Provide D/E Ratio
for Somalogic Inc.

Provide D/A Ratio
for Somalogic Inc.

Provide Interest Coverage Ratio
for Somalogic Inc.

Provide Altman Z-Score Ratio
for Somalogic Inc.

Provide Quick Ratio
for Somalogic Inc.

Provide Current Ratio
for Somalogic Inc.

Provide Cash Ratio
for Somalogic Inc.

What is the historical Revenue growth
over the last 5 years for Somalogic Inc?

What is the historical Net Income growth
over the last 5 years for Somalogic Inc?

What is the current Free Cash Flow
of Somalogic Inc?

Financials

Balance Sheet Decomposition
Somalogic Inc

Current Assets 494.1m
Cash & Short-Term Investments 453.8m
Receivables 20.7m
Other Current Assets 19.6m
Non-Current Assets 70.9m
PP&E 18.2m
Intangibles 27.1m
Other Non-Current Assets 25.6m
Current Liabilities 27.8m
Accounts Payable 11.5m
Accrued Liabilities 12.8m
Other Current Liabilities 3.5m
Non-Current Liabilities 40.5m
Other Non-Current Liabilities 40.5m
Efficiency

Earnings Waterfall
Somalogic Inc

Revenue
81.7m USD
Cost of Revenue
-48.1m USD
Gross Profit
33.6m USD
Operating Expenses
-183.3m USD
Operating Income
-149.7m USD
Other Expenses
19.3m USD
Net Income
-130.4m USD

Free Cash Flow Analysis
Somalogic Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

SLGC Profitability Score
Profitability Due Diligence

Somalogic Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
ROE is Increasing
Negative 1-Year Revenue Growth
21/100
Profitability
Score

Somalogic Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

SLGC Solvency Score
Solvency Due Diligence

Somalogic Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
67/100
Solvency
Score

Somalogic Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SLGC Price Targets Summary
Somalogic Inc

Wall Street analysts forecast SLGC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SLGC is 3.93 USD .

Lowest
Price Target
Not Available
Average
Price Target
3.93 USD
87% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

SLGC Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

SLGC Price
Somalogic Inc

1M 1M
-
6M 6M
-7%
1Y 1Y
-28%
3Y 3Y
-85%
5Y 5Y
-85%
10Y 10Y
-85%
Annual Price Range
2.1
52w Low
1.76
52w High
3.36
Price Metrics
Average Annual Return -46.72%
Standard Deviation of Annual Returns 43.46%
Max Drawdown -88%
Shares Statistics
Market Capitalization 396.3m USD
Shares Outstanding 188 679 008
Percentage of Shares Shorted 4.23%

SLGC Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Somalogic Inc Logo
Somalogic Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

396.3m USD

Dividend Yield

0%

Description

SomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. The company is headquartered in New York City, New York and currently employs 320 full-time employees. The company went IPO on 2021-02-23. The company develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein. The company offers SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. Its products include SomaScan Assay, SomaSignal Tests, SomaScan Panels, and SOMAmer Reagents. SomaScan Assay is utilized for Research Use Only (RUO) applications. Its SomaScan Assay measures approximately 7,000 protein target measurements in a single sample. SomaSignal Tests are available as laboratory developed tests (LDT) for use in obtaining proteomics information from patients and monitoring patients’ physiological states, among others. SomaScan Panels consists of two categories: fixed panels and custom panels. The company offers drug development, analysis of clinical trial and new human biology insights.

Contact

NEW YORK
New York City
C/O Corvex Management Lp, 667 Madison Avenue
+12124746724.0
https://somalogic.com/

IPO

2021-02-23

Employees

320

Officers

Exec. Chairman
Mr. Troy M. Cox M.B.A.
CEO & Director
Dr. Roy Smythe M.D.
Chief Financial Officer
Mr. Shaun M. Blakeman
Chief Technology Officer
Dr. Jason Cleveland Ph.D.
Chief Science Officer
Dr. Nebojsa Janjic Ph.D.
Gen. Counsel
Mr. Ruben Gutierrez J.D.
Show More
Sr. VP of People & Culture
Ms. Alison Marie Roelke
Chief Medical Officer
Dr. Stephen A. Williams BS, MB, Ph.D.
Exec. VP of Diagnostics Bus. Unit
Mr. Todd Johnson
Exec. VP of Life Sciences Bus. Unit
Mr. Adam Taich
Show Less

See Also

Discover More
What is the Intrinsic Value of one SLGC stock?

The intrinsic value of one SLGC stock under the Base Case scenario is 3.63 USD.

Is SLGC stock undervalued or overvalued?

Compared to the current market price of 2.1 USD, Somalogic Inc is Undervalued by 42%.